P.-O. Attman

1.3k total citations
33 papers, 964 citations indexed

About

P.-O. Attman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, P.-O. Attman has authored 33 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Nephrology. Recurrent topics in P.-O. Attman's work include Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Metabolism and Genetic Disorders (6 papers). P.-O. Attman is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Metabolism and Genetic Disorders (6 papers). P.-O. Attman collaborates with scholars based in Sweden, United States and France. P.-O. Attman's co-authors include Petar Alaupovic, Carolyn Knight‐Gibson, Ola Samuelsson, H. Mulec, Robert Larsson, Lars Weiss, B Kron, Marcelo Tavella, Mattias Aurell and Hans Wedel and has published in prestigious journals such as American Journal of Clinical Nutrition, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

P.-O. Attman

29 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.-O. Attman Sweden 18 521 381 317 211 91 33 964
Per‐Ola Attman Sweden 21 518 1.0× 462 1.2× 382 1.2× 199 0.9× 104 1.1× 44 1.3k
Christoph Wanner Germany 13 453 0.9× 372 1.0× 197 0.6× 187 0.9× 64 0.7× 22 1.1k
B L Kasiske United States 13 264 0.5× 456 1.2× 191 0.6× 180 0.9× 142 1.6× 16 1.3k
Erwin H. Fleischmann Germany 14 420 0.8× 245 0.6× 213 0.7× 280 1.3× 172 1.9× 19 884
Bertram L. Kasiske United States 11 840 1.6× 493 1.3× 573 1.8× 514 2.4× 111 1.2× 11 1.7k
H. Mulec Sweden 18 782 1.5× 357 0.9× 581 1.8× 690 3.3× 79 0.9× 20 1.5k
Gursharan Dogra Australia 22 551 1.1× 291 0.8× 228 0.7× 330 1.6× 107 1.2× 42 1.4k
Marcelo Costa Batista Brazil 19 332 0.6× 523 1.4× 449 1.4× 222 1.1× 117 1.3× 69 1.3k
Szu-Chun Hung Taiwan 18 530 1.0× 163 0.4× 231 0.7× 205 1.0× 200 2.2× 30 1.3k
Sören Madsen Denmark 12 329 0.6× 719 1.9× 200 0.6× 139 0.7× 25 0.3× 17 1.4k

Countries citing papers authored by P.-O. Attman

Since Specialization
Citations

This map shows the geographic impact of P.-O. Attman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.-O. Attman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.-O. Attman more than expected).

Fields of papers citing papers by P.-O. Attman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.-O. Attman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.-O. Attman. The network helps show where P.-O. Attman may publish in the future.

Co-authorship network of co-authors of P.-O. Attman

This figure shows the co-authorship network connecting the top 25 collaborators of P.-O. Attman. A scholar is included among the top collaborators of P.-O. Attman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.-O. Attman. P.-O. Attman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Attman, P.-O., et al.. (2015). Provision of Energy in Low-Protein Diets for Treatment of Renal Failure1. Contributions to nephrology. 72. 21–35.
2.
Attman, P.-O., et al.. (2015). Lipid Metabolism in Patients with Chronic Renal Failure in the Predialytic Phase. Contributions to nephrology. 65. 24–32.
3.
Attman, P.-O., et al.. (2015). Apolipoprotein Pattern in Patients with Chronic Renal Failure. Contributions to nephrology. 41. 328–331.
4.
5.
Samuelsson, Ola, P.-O. Attman, Ingrid Gause‐Nilsson, Maria Svensson, & Petar Alaupovic. (2013). Dual PPARα/γAgonism Normalizes Lipoprotein Profile of Renal Dyslipidemia. PPAR Research. 2013. 1–7. 3 indexed citations
6.
Attman, P.-O., Ola Samuelsson, & P. Alaupovic. (2011). The effect of decreasing renal function on lipoprotein profiles. Nephrology Dialysis Transplantation. 26(8). 2572–2575. 18 indexed citations
7.
Alaupovic, Petar, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (2006). Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency. Kidney International. 69(10). 1865–1871. 18 indexed citations
8.
Toigo, G., M. Aparicio, P.-O. Attman, et al.. (2000). Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2). Clinical Nutrition. 19(3). 197–207. 102 indexed citations
9.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1999). The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression. ˜The œNephron journals/Nephron journals. 82(4). 306–311. 26 indexed citations
10.
Attman, P.-O., Carolyn Knight‐Gibson, Marcelo Tavella, Ola Samuelsson, & Petar Alaupovic. (1998). The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrology Dialysis Transplantation. 13(11). 2833–2841. 44 indexed citations
11.
Samuelsson, Ola, H. Mulec, Carolyn Knight‐Gibson, et al.. (1997). Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrology Dialysis Transplantation. 12(9). 1908–1915. 179 indexed citations
12.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1997). Effect of Gemfibrozil on Lipoprotein Abnormalities in Chronic Renal Insufficiency: A Controlled Study in Human Chronic Renal Disease. Nephron. 75(3). 286–294. 21 indexed citations
13.
Attman, P.-O., Ola Samuelsson, & Petar Alaupovic. (1997). Lipid Abnormalities in Progressive Renal Insufficiency. Contributions to nephrology. 120. 1–10. 4 indexed citations
14.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1996). Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. Nephrology Dialysis Transplantation. 11(11). 2237–2243. 14 indexed citations
15.
Attman, P.-O. & P. Alaupovic. (1991). Abnormalities of lipoprotein composition in renal insufficiency. Progress in Lipid Research. 30(2-3). 275–279. 13 indexed citations
16.
Alaupovic, P., Marcelo Tavella, Jean‐Marie Bard, et al.. (1988). Lipoprotein Particles in Hypertriglyceridemic States. Advances in experimental medicine and biology. 243. 289–297. 13 indexed citations
17.
Attman, P.-O., et al.. (1986). Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus. European Heart Journal. 7(9). 779–791. 22 indexed citations
18.
Attman, P.-O., Jonathan A. Ewald, & B Isaksson. (1980). Body composition during long-term treatment of uremia with amino acid supplemented low-protein diet. American Journal of Clinical Nutrition. 33(4). 801–810. 23 indexed citations
19.
Brynger, H, J Ahlmén, P.-O. Attman, et al.. (1977). Graft survival and blood transfusion.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14. 290–5. 3 indexed citations
20.
Holmgren, Jan, Sven Hammarström, S. E. Holm, et al.. (1972). An Antigenic Relationship Between Human Kidney, Colon and the Common Antigen of Enterobacteriaceae. International Archives of Allergy and Immunology. 43(1). 89–97. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per‐Ola Attman Breakdown of academic impact, for papers by Christoph Wanner Breakdown of academic impact, for papers by B L Kasiske Breakdown of academic impact, for papers by Erwin H. Fleischmann Breakdown of academic impact, for papers by Bertram L. Kasiske Breakdown of academic impact, for papers by H. Mulec Breakdown of academic impact, for papers by Gursharan Dogra Breakdown of academic impact, for papers by Marcelo Costa Batista Breakdown of academic impact, for papers by Szu-Chun Hung Breakdown of academic impact, for papers by Sören Madsen
Rankless by CCL
2026